If the nuclear factor erythroid 2-related factor (NRF2) gene is overexpressed, tumor cells create an environment that is resistant to anticancer drugs, lowering the effectiveness of current chemotherapy drugs [55]. The gene discussed is NFE2L2; the disease is neoplasm.